FR2181658A1 - - Google Patents

Info

Publication number
FR2181658A1
FR2181658A1 FR7300567A FR7300567A FR2181658A1 FR 2181658 A1 FR2181658 A1 FR 2181658A1 FR 7300567 A FR7300567 A FR 7300567A FR 7300567 A FR7300567 A FR 7300567A FR 2181658 A1 FR2181658 A1 FR 2181658A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7300567A
Other versions
FR2181658B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
GlaxoSmithKline LLC
Original Assignee
Smith Kline and French Laboratories Ltd
GlaxoSmithKline LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd, GlaxoSmithKline LLC filed Critical Smith Kline and French Laboratories Ltd
Publication of FR2181658A1 publication Critical patent/FR2181658A1/fr
Application granted granted Critical
Publication of FR2181658B1 publication Critical patent/FR2181658B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
FR7300567A 1972-01-12 1973-01-09 Expired FR2181658B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21728372A 1972-01-12 1972-01-12
US23893272A 1972-03-28 1972-03-28

Publications (2)

Publication Number Publication Date
FR2181658A1 true FR2181658A1 (fr) 1973-12-07
FR2181658B1 FR2181658B1 (fr) 1976-06-25

Family

ID=26911792

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7300567A Expired FR2181658B1 (fr) 1972-01-12 1973-01-09

Country Status (7)

Country Link
JP (1) JPS49108089A (fr)
BE (1) BE793724A (fr)
CH (1) CH584228A5 (fr)
DE (1) DE2301509A1 (fr)
FR (1) FR2181658B1 (fr)
GB (1) GB1359811A (fr)
NL (1) NL7300487A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1192287B (it) * 1977-11-14 1988-03-31 Fujisawa Pharmaceutical Co Derivati di acido cefalosporanico ad azione farmaceutica e relativo procedimento di preparazione

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2111859A1 (fr) * 1970-10-27 1972-06-09 Ciba Geigy Ag

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2111859A1 (fr) * 1970-10-27 1972-06-09 Ciba Geigy Ag

Also Published As

Publication number Publication date
DE2301509A1 (de) 1973-07-19
JPS49108089A (fr) 1974-10-14
CH584228A5 (fr) 1977-01-31
NL7300487A (fr) 1973-07-16
BE793724A (fr) 1973-07-05
GB1359811A (en) 1974-07-10
FR2181658B1 (fr) 1976-06-25

Similar Documents

Publication Publication Date Title
JPS4949988A (fr)
FR2181658B1 (fr)
BR7310191D0 (fr)
CH570186A5 (fr)
CH589424A5 (fr)
BG20008A1 (fr)
BG20469A1 (fr)
BG20480A1 (fr)
BG19658A1 (fr)
CH1348472A4 (fr)
CH441173A4 (fr)
CH561486A5 (fr)
CH561670A5 (fr)
CH563237A5 (fr)
CH563553A5 (fr)
CH563676A5 (fr)
CH565246A5 (fr)
CH565301A5 (fr)
CH567003A5 (fr)
CH567700A5 (fr)
CH567900A5 (fr)
CH569171A5 (fr)
CH569920A5 (fr)
BG19349A1 (fr)
CH570340A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse